Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-myeloablative Conditioning”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005851
What this trial is testing

Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerStage IV Renal Cell Cancer
Fred Hutchinson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT01034449
What this trial is testing

Transplantation of Ex-vivo Expanded Cord Blood Stems Cells

Who this might be right for
Malignant Haematological Disease
University Hospital, Bordeaux 16
Testing effectiveness (Phase 2)Study completedNCT00305682
What this trial is testing

Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+1 more
Masonic Cancer Center, University of Minnesota 295
Testing effectiveness (Phase 2)Study completedNCT00282282
What this trial is testing

Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation

Who this might be right for
Graft Versus Host DiseaseGVHD
Dana-Farber Cancer Institute 31
Testing effectiveness (Phase 2)Study completedNCT03128359
What this trial is testing

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Who this might be right for
Acute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT03645824
What this trial is testing

Myelofibrosis Treated With Pacritinib Before aSCT. (HOVON134MF)

Who this might be right for
Myelofibrosis
Stichting Hemato-Oncologie voor Volwassenen Nederland 61
Testing effectiveness (Phase 2)Study completedNCT00948753
What this trial is testing

Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation

Who this might be right for
Graft-versus-host DiseaseHematopoietic Stem Cell Transplantation
Abramson Cancer Center at Penn Medicine 38
Testing effectiveness (Phase 2)Study completedNCT00004145
What this trial is testing

Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Chicago 16
Not applicableLooking for participantsNCT06809075
What this trial is testing

Immunological Reset to Allow Access to HLA Compatible Transplantation in Highly Sensitized Kidney Transplant Candidates Through Non-myeloablative Autologous Stemm Cell Transplantation

Who this might be right for
Kidney DiseaseKidney TransplantKidney Transplant Candidates
Hospital Universitari Vall d'Hebron Research Institute 10
Testing effectiveness (Phase 2)Study completedNCT00309842
What this trial is testing

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Masonic Cancer Center, University of Minnesota 213
Early research (Phase 1)Study completedNCT01853358
What this trial is testing

Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation

Who this might be right for
Hematological Malignancy
Institut Paoli-Calmettes 17
Testing effectiveness (Phase 2)Ended earlyNCT02111863
What this trial is testing

Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Who this might be right for
MelanomaSkin Cancer
National Cancer Institute (NCI) 6
Not applicableLooking for participantsNCT04528355
What this trial is testing

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more
Paul Szabolcs 50
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Testing effectiveness (Phase 2)Study completedNCT02424968
What this trial is testing

CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

Who this might be right for
Acute Myeloid LeukemiaB-Cell Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+4 more
Robert Lowsky 18
Very early researchEnded earlyNCT03421756
What this trial is testing

Stem Cell Transplant in Patients With Severe Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Kathleen Dorritie 1
Testing effectiveness (Phase 2)Study completedNCT01208896
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma

Who this might be right for
Lymphoma, FollicularStem Cell Transplantation
University Hospital, Bordeaux 32
Testing effectiveness (Phase 2)Study completedNCT00031005
What this trial is testing

Stem Cell Transplantation to Treat Leukocyte Adhesion Deficiency

Who this might be right for
Leukocyte-Adhesion Deficiency Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Study completedNCT00580034
What this trial is testing

Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath

Who this might be right for
LymphomaMyelomaLeukemia+2 more
David Rizzieri, MD 176
Testing effectiveness (Phase 2)UnknownNCT04383067
What this trial is testing

A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Urothelial Carcinoma Patients

Who this might be right for
Metastatic Urothelial Carcinoma
Sheba Medical Center 20
Next Page